The treatment of GBM cells with TGF-β upregulates the expressions of fibronectin and COL5A1 mesenchymal markers, resulting in aggressive tumors showing increased sphere formation and a spindle-shaped morphology, and the effect is reversed with the inhibition of TGF-β [141]. This evidence concerns the gene TGFB1 and glioblastoma.